Scientific Strategy Director (Oncology - Pathology, Sequencing)
Roche
About this role
The Scientific Strategy Director for Oncology (Pathology, Sequencing) at Roche leads US scientific strategy across multiple diagnostic portfolios, translating complex science into actionable medical plans and driving adoption of diagnostic solutions. The role includes shaping long-term vision, guiding a team of senior scientific managers, and partnering cross-functionally and externally to align on evidence generation and product integration to improve patient care.
Skills
Qualifications
About Roche
roche.comAs a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Recent company news
ReutersRoche chairman still expects diagnostics hit from US tariffs
4 days ago
Oncology PipelineRoche flunks its first-line degrader test | ApexOnco - Clinical Trials news and analysis
3 days ago
BioWorld MedTechRoche to invest ₩710B in South Korea over five years
1 day ago
Bloomberg.comRoche Breast-Cancer Drug Combination Misses Target in Study
3 days ago
Fierce BiotechLilly pledges $500M to South Korea biopharma industry, following Roche’s lead
1 day ago
About Roche
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Roche.
Salary
$175k – $326k
per year
More jobs at Roche
Similar Jobs
Medical Scientific Liaison Oncology
City of Duncan, Oklahoma
Medical Scientific Liaison (Oncology)
Diversity Employment
ED, Evidence Generation TA Head - Oncology
Diversity Employment
Director of Pathology Diagnostics
AstraZeneca
Associate Director, Translational Pathology
Bristol Myers Squibb
Oncology Scientific Advisor
GSK plc